Effect of a Third Dose of SARS-CoV-2 mRNA BNT162b2 Vaccine on Humoral and Cellular Responses and Serum Anti-HLA Antibodies in Kidney Transplant Recipients
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of a Third Dose of SARS-CoV-2 mRNA BNT162b2 Vaccine on Humoral and Cellular Responses and Serum Anti-HLA Antibodies in Kidney Transplant Recipients
Authors
Keywords
-
Journal
Vaccines
Volume 10, Issue 6, Pages 921
Publisher
MDPI AG
Online
2022-06-13
DOI
10.3390/vaccines10060921
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibody Response to a Fourth Messenger RNA COVID-19 Vaccine Dose in Kidney Transplant Recipients: A Case Series
- (2022) Sophie Caillard et al. ANNALS OF INTERNAL MEDICINE
- Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults — United States, August–December 2021
- (2022) Mark W. Tenforde et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Efficacy and Safety of Third Dose of the COVID-19 Vaccine among Solid Organ Transplant Recipients: A Systemic Review and Meta-Analysis
- (2022) Orly Efros et al. Vaccines
- Boosting Humoral Immunity from mRNA COVID-19 Vaccines in Kidney Transplant Recipients
- (2022) Leszek Tylicki et al. Vaccines
- Seroprevalence of SARS-CoV-2 in 1922 blood donors from the Lodi Red Zone and adjacent Lodi metropolitan and suburban area
- (2021) Irene Cassaniti et al. CLINICAL MICROBIOLOGY AND INFECTION
- Immunogenicity of SARS‐CoV‐2 BNT162b2 vaccine in solid organ transplant recipients
- (2021) Smaragdi Marinaki et al. AMERICAN JOURNAL OF TRANSPLANTATION
- SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay
- (2021) Irene Cassaniti et al. CLINICAL MICROBIOLOGY AND INFECTION
- Antibody response to mRNA SARS-CoV-2 vaccine among kidney transplant recipients – Prospective cohort study
- (2021) Benaya Rozen-Zvi et al. CLINICAL MICROBIOLOGY AND INFECTION
- Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept
- (2021) Nathalie Chavarot et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Efficiency of a boost with a third dose of anti‐SARS‐CoV‐2 messenger RNA‐based vaccines in solid organ transplant recipients
- (2021) Arnaud Del Bello et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses
- (2021) Ilies Benotmane et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis Patients
- (2021) Dominique Bertrand et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine
- (2021) Valerie Oberhardt et al. NATURE
- Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
- (2021) Nassim Kamar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune Response Post-SARS-CoV-2 mRNA Vaccination in Kidney-Transplant Recipients Receiving Belatacept
- (2021) Johan Noble et al. TRANSPLANTATION
- Photopheresis Abates the Anti-HLA Antibody Titer and Renal Failure Progression in Chronic Antibody-Mediated Rejection
- (2021) Marilena Gregorini et al. Biology-Basel
- SARS‐COV‐2 vaccination with BNT162B2 in renal transplant patients: Risk factors for impaired response and immunological implications
- (2021) Gianluca Russo et al. CLINICAL TRANSPLANTATION
- Effectiveness of a Third Dose of BNT162b2 mRNA Vaccine
- (2021) Yaki Saciuk et al. JOURNAL OF INFECTIOUS DISEASES
- Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study
- (2021) Noam Barda et al. LANCET
- Impact of immunosuppression on the immune response to SARS‐CoV‐2 infection: A mechanistic study
- (2021) Victoria G. Hall et al. Transplant Infectious Disease
- Divergent Immune Responses to SARS-CoV-2 Vaccines in Immunocompromised Patients
- (2021) Stanley C. Jordan et al. TRANSPLANTATION
- Immune Response to BNT162b2 in Solid Organ Transplant Recipients: Negative Impact of Mycophenolate and High Responsiveness of SARS-CoV-2 Recovered Subjects against Delta Variant
- (2021) Irene Cassaniti et al. Microorganisms
- Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020
- (2020) Elena Percivalle et al. Eurosurveillance
- Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy
- (2020) Lorenzo Cavagna et al. Microorganisms
- Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
- (2020) Yanchun Peng et al. NATURE IMMUNOLOGY
- Impact of COVID‐19 in solid organ transplant recipients
- (2020) Lara Danziger‐Isakov et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Does vaccination in solid-organ transplant recipients result in adverse immunologic sequelae? A systematic review and meta-analysis
- (2018) William R. Mulley et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- The role of therapeutic drug monitoring in the treatment of cytomegalovirus disease in kidney transplantation
- (2012) Giulia Bedino et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started